Elevated CXCL1 increases hepatocellular carcinoma aggressiveness and is inhibited by miRNA-200a

In this study, we investigated the value of measurement of the chemokine CXCL1 in clinical management of hepatocellular carcinoma (HCC) and its possible role in the molecular pathogenesis of HCC. High CXCL1 expression predicted recurrence in HCC patients and promoted tumor progression in both in viv...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Xiao, Li, Zhao, Gao, Jie, Gao, Peng-Ji, Ni, Yan-bing, Zhu, Ji-Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323138/
https://www.ncbi.nlm.nih.gov/pubmed/27542259
http://dx.doi.org/10.18632/oncotarget.11350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323138/
https://www.ncbi.nlm.nih.gov/pubmed/27542259
http://dx.doi.org/10.18632/oncotarget.11350

Ejemplares similares